References
Bengs S, Haider A, Warnock GI, Fiechter M, Pargaetzi Y, Rampidis G, et al. Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. Eur J Nucl Med Mol Imaging. 2020. https://doi.org/10.1007/s00259-020-05106-0.
Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9. https://doi.org/10.1126/scitranslmed.aal2658.
Oikonomou EK, Marwan M, Desai MY, Mancio J, Alashi A, Hutt Centeno E, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392:929–39. https://doi.org/10.1016/S0140-6736(18)31114-0.
Antoniades C, Shirodaria C. Detecting coronary inflammation with perivascular fat attenuation imaging. 2019;12:2011–4. doi:https://doi.org/10.1016/j.jcmg.2018.12.024.
Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080. https://doi.org/10.1136/bmj.332.7549.1080.
Antoniades C, Antonopoulos AS, Deanfield J. Imaging residual inflammatory cardiovascular risk. Eur Heart J. 2020;41:748–58. https://doi.org/10.1093/eurheartj/ehz474.
Oikonomou EK, Williams MC, Kotanidis CP, Desai MY, Marwan M, Antonopoulos AS, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40:3529–43. https://doi.org/10.1093/eurheartj/ehz592.
Elnabawi Y, Oikonomou E, Dey A, Mancio J, Rodante J, Gelfand J, et al. Treatment with biologic therapy in psoriasis is associated with a reduction in coronary artery inflammation, assessed by perivascular Fat Attenuation Index. J Am Coll Cardiol. 2019;73:87. https://doi.org/10.1016/S0735-1097(19)30695-3.
Dai X, Yu L, Lu Z, Shen C, Tao X, Zhang J. Serial change of perivascular fat attenuation index after statin treatment: insights from a coronary CT angiography follow-up study. Int J Cardiol. 2020;319:144–9. https://doi.org/10.1016/j.ijcard.2020.06.008.
Funding
CA is supported by the British Heart Foundation (FS/16/15/32047 and TG/19/2/34831), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and Innovate UK.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
AA and CA are inventors of intellectual property relevant to CT imaging (AA/CA: GB2015/052359, GR2018/0100490, GR2018/0100510; CA: GB2015/052359, GB2016/1620494.3, GB2018/1818049.9). CA is founder, shareholder, and director of Caristo Diagnostics Ltd., a spin-out company of the University of Oxford; he is also head of Oxford Academic Cardiovascular CT Core lab.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Cardiology.
Rights and permissions
About this article
Cite this article
Antonopoulos, A.S., Antoniades, C. Reply to: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring. Eur J Nucl Med Mol Imaging 48, 1707–1708 (2021). https://doi.org/10.1007/s00259-020-05171-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-020-05171-5